FDA Approves First AI Device to Detect Diabetic Retinopathy

Surgical Indications for Nonrhegmatogenous Retinal Detachment

How acting sooner than later may preserve vision in selected cases.

Durable Treatment for Macular Degeneration

Innovations bring promise for more durable drugs, combination therapies, and sustained-release devices.

Aspirin Use and Age-Related Macular Degeneration

Well-documented cardiovascular benefits of aspirin outweigh unproven added risk of AMD.

Wet AMD in 2018: Drugs in Development

Research efforts are going beyond targeting VEGF.

Emerging Treatments for X-Linked Retinitis Pigmentosa

Clinical trials are under way, testing gene therapies that could preserve sight in patients with a severe form of retinitis pigmentosa.

UPFRONT: An Eye on Retina Innovators

SUBSPECIALTY NEWS: Suprachoroidal delivery meets primary endpoints, AI studies for retinal disease proliferate, and more

RETINA CONVERSATIONS: A Conversation With Cedric Francois, MD, PhD

The complement inhibitor APL-2 has potential as an effective treatment for geographic atrophy.

INNOVATION IN RETINA: Napoleone Ferrara, MD: Not Resting on His Laurels

Discoverer of VEGF has moved on to academia.

CODING Q&A: Keeping Up With Floaters

Two different CPT codes may be used for laser vitreolysis of floaters.

NEW PRODUCT APPLICATIONS: Imaging Precision at Its Finest

Topcon’s DRI OCT Triton Series offers everything needed for optimum ocular visualization and imaging.

CLINICAL TRIAL UPDATE